Source: Stem Cell Reviews and Reports. Unidades: FM, IB
Subjects: CÉLULAS-TRONCO, FIBROBLASTOS, CRANIOSSINOSTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YEH, Erika et al. FGFR2 mutation confers a less drastic gain of function in mesenchymal stem cells than in fibroblasts. Stem Cell Reviews and Reports, v. No 2011, p. on-line, 2012Tradução . . Disponível em: https://doi.org/10.1007/s12015-011-9327-6. Acesso em: 19 out. 2024.APA
Yeh, E., Atique, R., Ishiy, F. A. A., Fanganiello, R. D., Alonso, N., Matushita, H., et al. (2012). FGFR2 mutation confers a less drastic gain of function in mesenchymal stem cells than in fibroblasts. Stem Cell Reviews and Reports, No 2011, on-line. doi:10.1007/s12015-011-9327-6NLM
Yeh E, Atique R, Ishiy FAA, Fanganiello RD, Alonso N, Matushita H, Rocha KM da, Passos-Bueno MR. FGFR2 mutation confers a less drastic gain of function in mesenchymal stem cells than in fibroblasts [Internet]. Stem Cell Reviews and Reports. 2012 ; No 2011 on-line.[citado 2024 out. 19 ] Available from: https://doi.org/10.1007/s12015-011-9327-6Vancouver
Yeh E, Atique R, Ishiy FAA, Fanganiello RD, Alonso N, Matushita H, Rocha KM da, Passos-Bueno MR. FGFR2 mutation confers a less drastic gain of function in mesenchymal stem cells than in fibroblasts [Internet]. Stem Cell Reviews and Reports. 2012 ; No 2011 on-line.[citado 2024 out. 19 ] Available from: https://doi.org/10.1007/s12015-011-9327-6